Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome by Minegishi, Yoshiyuki et al.
ARTICLE
The Rockefeller University Press  $30.00
J. Exp. Med. Vol. 206 No. 6  1291-1301
www.jem.org/cgi/doi/10.1084/jem.20082767
1291
The identification of Th17 cells as a third sub-
set of helper T cells has illuminated the fact that 
distinct  subsets  of  helper  T  cells  have  been 
evolved to protect our body from infections by 
various  types  of  microorganisms  and  are  in-
volved differently in the induction and exac-
erbation of various immunological disorders. 
Th17 cells are characterized and distinguished 
from IFN-–producing Th1 cells and IL-4–
producing  Th2  cells  by  their  production  of   
so-called Th17 cytokines including IL-17 (IL-
17A), IL-17F, and IL-22 (1–4). For their dif-
ferentiation from naive CD4 T cells, Th17 cells 
require  different  cytokines  and  transcription 
factors than do Th1, Th2, or regulatory T cells. 
The roles of Th17 cells in immune responses 
are also different from those of other helper   
T cells. In particular, their pathological roles   
in autoimmune and inflammatory diseases, in-
cluding multiple sclerosis, rheumatoid arthritis, 
psoriasis, and inflammatory bowel diseases, have 
been studied extensively (5–10).
Although the functions of Th17 cells under 
physiological conditions have not been com-
pletely elucidated, accumulating data suggest that 
Th17 cells play crucial roles in the host de-
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Hyper-IgE syndrome (HIES) is a primary immunodeficiency characterized by atopic manifes-
tations and susceptibility to infections with extracellular pathogens, typically Staphylococ-
cus aureus, which preferentially affect the skin and lung. Previous studies reported the 
defective differentiation of T helper 17 (Th17) cells in HIES patients caused by hypo-
morphic STAT3 mutations. However, the apparent contradiction between the systemic Th17 
deficiency and the skin/lung-restricted susceptibility to staphylococcal infections remains 
puzzling. We present a possible molecular explanation for this enigmatic contradiction. 
HIES T cells showed impaired production of Th17 cytokines but normal production of 
classical proinflammatory cytokines including interleukin 1. Normal human keratinocytes 
and bronchial epithelial cells were deeply dependent on the synergistic action of Th17 
cytokines and classical proinflammatory cytokines for their production of antistaphylococ-
cal factors, including neutrophil-recruiting chemokines and antimicrobial peptides. In 
contrast, other cell types were efficiently stimulated with the classical proinflammatory 
cytokines alone to produce such factors. Accordingly, keratinocytes and bronchial epithelial 
cells, unlike other cell types, failed to produce antistaphylococcal factors in response to 
HIES T cell–derived cytokines. These results appear to explain, at least in part, why HIES 
patients suffer from recurrent staphylococcal infections confined to the skin and lung in 
contrast to more systemic infections in neutrophil-deficient patients.
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which was insufficient for triggering keratinocytes and bron-
chial epithelial cells but sufficient for other cell types to pro-
duce antistaphylococcal factors. Th17 cytokines and classical 
proinflammatory cytokines synergistically stimulated keratino-
cytes and bronchial epithelial cells, but the synergy was not 
seen in other types of cells. These findings provide a possible 
molecular explanation for the apparent contradiction between 
the systemic Th17 deficiency and the skin and lung-restricted 
staphylococcal infections in HIES patients.
RESULTS
HIES T cells produce little or no Th17 cytokines and fail  
to stimulate keratinocytes to secrete neutrophil-recruiting 
chemokines and BDs
We first examined the profile of cytokines produced by T cells 
from our cohort of HIES patients whose STAT3 genes carried 
mutations. The amounts of IL-17A and IL-22 secreted from 
the patients’ T cells upon stimulation with anti-CD3 and anti-
CD28  mAbs  were  invariably  only 5–10%  of  those  from 
healthy control subjects, which is in accordance with previous 
results (23–26), whereas the production levels of IFN-, IL-1, 
and TNF- were comparable in the two groups (Fig. 1).   
Real-time quantitative RT-PCR demonstrated that the up-
regulation of IL-17F expression by the patients’ T cells was also 
impaired (unpublished data). Thus, the patients’ T cells showed 
a selective defect in the production of Th17 cytokines.
We next investigated the functional consequences of the 
Th17 deficiency in the context of staphylococcal infections of 
the skin. Normal human primary epidermal keratinocytes were 
cultured in vitro with culture supernatants from HIES patients’ 
or control subjects’ T cells that had been unstimulated or stim-
ulated with anti-CD3 plus anti-CD28. The expression and 
production of two chemokines, CXCL8 (IL-8) and CCL2, 
was up-regulated in the keratinocytes cultured with the condi-
tioned medium from activated control T cells (Fig. 2 A and 
Fig. S1). In contrast, although CCL2 was also up-regulated by 
the conditioned medium from activated HIES T cells, CXCL8 
was not (Fig. 2 A and Fig. S1). Among the three antimicrobial 
peptides (BDs) examined, at the mRNA and protein level the 
expression of BD1 but not BD2 or BD3 was up-regulated in 
keratinocytes when they were stimulated with conditioned 
medium from the T cells of HIES patients, but all three were 
up-regulated by the conditioned medium from the control 
subjects’ T cells (Fig. 2 A and Fig. S1). Thus, the HIES pa-
tients’ T cells could not stimulate keratinocytes to produce a 
significant  amount  of  the  neutrophil-recruiting  chemokine 
CXCL8 or the antimicrobial peptides BD2 and BD3, but they 
could stimulate the up-regulation of CCL2 and BD1.
T cell–derived Th17 cytokines are responsible  
for the production of CXCL8 and BDs from keratinocytes
When the supernatants from activated control T cells were 
treated with the combination of anti–IL-17A and anti–IL-22 
blocking mAbs before incubation with keratinocytes, their 
capability of stimulating keratinocytes to up-regulate CXCL8, 
BD2, and BD3 was diminished to the level displayed by the 
not efficiently cleared by Th1- and Th2-type immune re-
sponses. Th17-type cytokines IL-17A and IL-17F are impor-
tant for the recruitment of neutrophils (11), whereas IL-22 
induces the production of antimicrobial peptides -defensin 
(BD) 2 and BD3 by keratinocytes, through the activation of 
STAT3 (12–14). Mice with a homozygous deletion of the 
gene encoding the IL-17RA (IL-17 receptor A) and mice 
that do not produce IL-22 are susceptible to lung infection 
by the Gram-negative bacteria Klebsiella pneumoniae and My-
coplasm pulmonis (15–17). Mice that produce neither IL-17A 
nor IL-17F are susceptible to skin infection by the Gram-
positive bacteria Staphylococcus aureus (18). Administration of 
anti–IL-17A neutralizing antibodies impairs both the intra-
abdominal abscess formation in response to Bacteroides fragilis 
and Escherichia coli (19–21) and the host defense against sys-
temic infection by the fungus Candida albicans (22). These 
data indicate that Th17 cells play a key role in immune re-
sponses to extracellular bacteria and fungi in mice. In con-
trast, the anti-pathogenic roles of Th17 cells in humans are 
relatively uncertain.
Recent studies demonstrated that the differentiation of hu-
man Th17 cells was defective in patients with hyper-IgE syn-
drome (HIES) (23–26). HIES is a primary immunodeficiency 
disease caused by dominant-negative mutations in the DNA-
binding domain, SH2 domain, or transactivating domain of 
STAT3  (26–28).  As  expected  from  the  important  roles  of 
STAT3 in transducing signals for a variety of cytokines, growth 
factors, and hormones, patients with HIES display complex 
clinical manifestations in multiple organs, including atopic der-
matitis with high serum IgE levels and abnormalities of the 
bones and teeth (29–32). Most patients suffer from recurrent 
infections by fungi and bacteria, predominantly the Gram-posi-
tive bacteria S. aureus. The presence of these infections suggests 
that Th17 cells play a crucial role in protection from extracellu-
lar pathogens, not only in mice but also in humans. However, 
curiously, the staphylococcal infections in HIES patients are of-
ten confined to the skin and lung and manifest clinically as skin 
abscesses and cyst-forming pneumonia. These skin- and lung-
restricted infections are in sharp contrast to the pattern of infec-
tion observed in patients with a neutrophil deficiency. For 
example,  in  patients  with  chronic  granulomatous  disease 
(CGD), staphylococcal infections occur in a wide variety of or-
gans including the lung, lymph nodes, skin, liver, bone, gastro-
intestinal tract, kidney, and brain (33). Thus, it remains elusive 
why HIES patients suffer from skin- and lung-restricted staphy-
lococcal infections in spite of their systemic Th17 deficiency.
In  the  present  study,  we  explored  possible  molecular 
mechanisms underlying the recurrent staphylococcal infections 
confined to the skin and lung in HIES patients. We found that 
primary human keratinocytes and bronchial epithelial cells dis-
played a much stronger dependence than other cell types on 
Th17 cytokines in their production of antistaphylococcal fac-
tors including the neutrophil-recruiting chemokines and anti-
bacterial peptides. T cells from HIES patients, in spite of their 
defect in production of Th17 cytokines, showed normal pro-
duction of other proinflammatory cytokines, including IL-1, JEM VOL. 206, June 8, 2009 
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of human primary cells for their ability to secrete chemokines 
and BDs in response to T cell–derived factors including Th17 
cytokines. We first compared their responsiveness to culture 
supernatants from either control or patient T cells that were 
activated with anti-CD3 and anti-CD28 mAbs. Primary bron-
chial epithelial cells responded to the T cell conditioned me-
dium just as the primary keratinocytes did. That is, both cell 
types up-regulated the expression and production of chemo-
kines (CXCL8 and CXCL1) and BDs (BD2 and BD3) when 
incubated with the supernatants from control T cells but not 
from HIES T cells (Fig. 3 A and Fig. S3). Interestingly, pri-
mary dermal fibroblasts, human umbilical vein endothelial 
cells (HUVEC), and human lung microvascular endothelial 
cells (HMVEC-L) responded equally well, in terms of their 
secretion of the chemokines and BDs, to the supernatants from 
control or patient T cells (Fig. 3 A and Fig. S3). This was also 
true for the expression and production of CXCL8 and CXCL1 
by human macrophages (Fig. 3 A and Fig. S3). Human mac-
rophages did not produce detectable amounts of BDs. Thus, 
keratinocytes and bronchial epithelial cells responded differ-
ently to T cell–derived factors than the other cell types tested 
and appeared to be much more dependent on Th17 cytokines 
for their induction to secrete chemokines and BDs.
These findings prompted us to examine the responses of 
different cell types to individual cytokines and their combi-
nations, including the Th17 cytokines (IL-17A, IL-17F, and 
IL-22), classical proinflammatory cytokines (IL-1, TNF-, and 
IFN-), or both. Keratinocytes secreted CXCL8 in response 
to IL-17A, IL-22, IL-1, or TNF- in a dose-dependent 
HIES patients’ T cells (Fig. 2 A and Fig. S1). Either anti–IL-
17A or anti–IL-22 alone was less effective than their combi-
nation (Fig. S2). Thus, the defective production of chemokines 
and BDs by keratinocytes in response to the conditioned me-
dium from the patients’ T cells was attributable to the T cells’ 
defective production of Th17 cytokines.
We next examined the direct effect of the keratinocyte-
derived factors on the growth of Staphylococcus aureus using a 
colony-forming assay (Fig. 2, B and C). When bacteria were 
cultured with the culture supernatant from keratinocytes stim-
ulated by control T cells, the number of bacterial colonies was 
reduced to 60% as compared with that when cultured with 
control medium. However, this was not the case when HIES 
T cells were used to stimulate keratinocytes. The antibacterial 
activity was completely abrogated when the culture superna-
tant from the control T cells was pretreated with the blocking 
mAbs for IL-17A and IL-22 before it was added to the kerati-
nocytes (Fig. 2 B), and it was attenuated when the keratinocyte 
supernatants were pretreated with an anti-BD3 mAb before 
their application to the bacterial culture (Fig. 2 C). These re-
sults indicated that control but not HIES T cells produced 
Th17 cytokines that, in turn, acted on keratinocytes to elicit 
their secretion of antimicrobial factors including BD3.
Keratinocytes and bronchial epithelial cells display a greater 
dependence on Th17 cytokines for their production  
of chemokines and BDs than other cell types
To learn why the staphylococcal infections are confined to the 
skin and lung in HIES patients, we analyzed different lineages 
Figure 1.  HIES T cells produce greatly reduced amounts of Th17 cytokines and normal amounts of classical proinflammatory cytokines upon 
activation. PBMCs from HIES patients (Pt.) and control subjects (Cont.; n = 8 each, indicated by dots) were stimulated (+) or not () with anti-CD3 and 
anti-CD28 for 72 h, and the concentration of the indicated cytokines in their culture supernatants was determined by ELISA. The results shown are repre-
sentative of three independent experiments. **, P < 0.01.1294 SKIN/LUNG-RESTRICTED INFECTION IN STAT3 DEFICIENCY | Minegishi et al.
flammatory cytokines affected not only the expression of 
CXCL8 but also that of other chemokines (CXCL1 and 
CXCL2) and BDs (BD2 and BD3; Fig. S6 A). In accordance 
with this finding, the supernatants of keratinocytes stimu-
lated with the Th17–classical cytokine combination caused 
robust neutrophil chemotaxis compared with the superna-
tants from keratinocytes stimulated with only one of the 
cocktails (Fig. S6 B).
Previous studies demonstrated that the stimulation of ke-
ratinocytes with toll-like receptor (TLR) 2 ligands induces 
the production of the chemokines and antimicrobial peptides 
(34, 35). In agreement with this, the keratinocytes showed 
up-regulated CXCL8 secretion and BD expression in re-
sponse to lipoteichoic acid, peptidoglycan, or fixed S. aureus, 
but the extent of up-regulation was <10% of that observed 
after stimulation with the combination of Th17 and proin-
flammatory cytokines (Fig. S6 C).
Molecular mechanisms underlying the unique responsiveness 
of keratinocytes and bronchial epithelial cells to Th17 
cytokines in synergy with other proinflammatory cytokines
To explore the possible molecular basis of the poorer re-
sponse of keratinocytes and bronchial epithelial cells to the 
manner, but they responded poorly to IL-17F and IFN- 
(Fig. S4 A). Using the Th17 cytokine cocktail or the classical 
proinflammatory cytokine cocktail resulted in some additive 
effect on the keratinocytes’ secretion of CXCL8 (Fig. S4,   
B and C). In contrast, the combination of both types of cyto-
kines dramatically enhanced the CXCL8 production by the 
keratinocytes (Fig. 3 B and Fig. S5). This was also the case   
for bronchial epithelial cells (Fig. 3 B). In contrast, fibroblasts, 
HUVEC, and HMVEC-L secreted a large quantity of CXCL8 
in response to the classical proinflammatory cytokine cocktail, 
but the further addition of Th17 cytokine cocktail caused no 
significant enhancement of CXCL8 production (Fig. 3 B). 
Furthermore, the Th17 cytokine cocktail was much less effec-
tive in stimulating fibroblasts, HUVEC, and HMVEC-L than 
the classical cytokine cocktail, and the amount of CXCL8 
produced by the Th17 cytokine cocktail-treated fibroblasts, 
HUVEC, and HMVEC-L was 10–30% of that produced by 
stimulation  with  the  classical  proinflammatory  cocktail.   
Macrophages responded to the cytokines in a pattern similar 
to fibroblasts, HUVEC, and HMVEC-L, although the mac-
rophages produced 10× less CXCL8 than the others.
In keratinocytes and bronchial epithelial cells, the marked 
synergy caused by combining the Th17 and classical proin-
Figure 2.  Supernatants of activated HIES T cells fail to stimulate keratinocytes to secrete significant amounts of antibacterial factors.  
In the presence or absence of anti–IL-17A plus anti–IL-22 (A and B), anti-BD3 (C), or isotype-matched control antibodies, primary human keratinocytes were 
incubated for 48 h with the supernatants of HIES (Pt.) or control (Cont.) T cells that had been stimulated (+) or not () with anti-CD3 and anti-CD28 for 
72 h as in Fig. 1. (A) The concentration of CXCL8, BD2, and BD3 in keratinocytes supernatants was determined by ELISA. Representative data from one 
patient and one control are shown (mean ± SD; n = 3), and similar results were obtained from the other patients and controls. (B and C) The culture su-
pernatants of keratinocytes were analyzed for their antistaphylococcal activity by the colony assay (mean ± SD; n = 3). The results shown in are represen-
tative of at least three independent experiments. **, P < 0.01.JEM VOL. 206, June 8, 2009 
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much poorer up-regulation of c-Fos and IL-6 than fibroblasts 
in response to IL-1 (Fig. 4 C). This appeared to partly ex-
plain why keratinocytes and bronchial epithelial cells were 
less sensitive to the classical proinflammatory cytokines than 
fibroblasts but did not account for the strong synergy be-
tween the Th17 and the classical proinflammatory cytokines 
in the keratinocytes. Therefore, we next examined the possi-
ble cross-talk between the two types of cytokines in terms of 
the regulation of cytokine receptor expression.
We found that the expression of the Th17 cytokine re-
ceptors IL-17RA, IL-17RC, and IL-22R was up-regulate, in 
keratinocytes incubated with the classical proinflammatory 
classical proinflammatory cytokines, as compared with the 
other types of cells, we analyzed the expression of the classical 
cytokine IL-1R1 (IL-1 receptor) and its antagonists IL-1R2 
and IL-1Ra (Fig. 4, A and B). Compared with fibroblasts, 
keratinocytes expressed 1/600th of IL-1R1 transcripts, 170-
fold more IL-1Ra transcripts, and 260-fold more IL-1R2 
(Fig. 4 A). The great difference in their expression between 
keratinocytes and fibroblasts was also confirmed at the pro-
tein level (Fig. 4 B). Bronchial epithelial cells showed the ke-
ratinocyte-type expression, whereas HUVEC and HMVEC-L 
displayed the fibroblast-type expression (Fig. 4 A and not de-
picted). Consistent with this result, keratinocytes showed a 
Figure 3.  Keratinocytes and bronchial epithelial cells show greater dependence on Th17 cytokines for the production of chemokines and 
BDs than other cell types. Primary human keratinocytes, bronchial epithelial cells, dermal fibroblasts, endothelial cells (HUVEC and HMVEC-L), and mac-
rophages were incubated for 48 h with T cell supernatants that were prepared as described in Fig. 1 A or with the Th17 cytokine cocktail (Th17 mix:  
IL-17A + IL-17F + IL-22), the classical proinflammatory cytokine cocktail (classical mix: TNF- + IL-1 + IFN-), or the combination of both (both mix; B).  
The concentration of CXCL8, BD2, and BD3 in their culture supernatants was determined by ELISA. Representative data from one patient and one control  
are shown in A (mean ± SD; n = 3), and similar results were obtained from the other patients and controls. The results shown are representative of at  
least three independent experiments. **, P < 0.01.1296 SKIN/LUNG-RESTRICTED INFECTION IN STAT3 DEFICIENCY | Minegishi et al.
Figure 4.  Distinct expression and regulation of the cytokine receptors in keratinocytes and fibroblasts compared with those in other cell 
types. (A) The expression of IL-1R1, IL-1Ra, and IL-1R2 in the indicated cells was determined by quantitative RT-PCR. Data shown were normalized to 
HPRT levels, and the level of expression in keratinocytes was defined as 1.0. (B) IL-1R1, IL-1R2, and IL-1Ra proteins in keratinocytes and fibroblasts were 
detected by immunoblotting. (C) Keratinocytes and fibroblasts were cultured for 15 min with the indicated concentration of IL-1 and analyzed by quan-
titative RT-PCR for the expression of c-Fos and IL-6. Data shown were normalized to HPRT levels, and the level of expression in cells cultured without  
IL-1 was defined as 1.0 for each cell type. (D) Keratinocytes cultured as in Fig. 3 B were analyzed by quantitative RT-PCR for the expression of IL-17RA, 
IL-17RC, and IL-22R. The data shown were normalized to the HPRT levels, and the level of expression in cells cultured without any added cytokine was 
defined as 1.0. The results shown are representative of three independent experiments. Error bars show mean ± SD (n = 3). *, P < 0.05; **, P < 0.01.JEM VOL. 206, June 8, 2009 
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superantigens for T cells, staphylococcal enterotoxin B (SEB), 
HIES patients’ T cells produced drastically reduced amounts 
of IL-17A and IL-22, <10% of those produced by control   
T cells (Fig. 5 A). In contrast, the IL-1 production was   
normal, and the IFN- and TNF- production was even   
enhanced in SEB-stimulated HIES T cells (Fig. 5 A). It is of 
note that the supernatants of SEB-stimulated HIES T cells 
showed much poorer ability to induce the production of 
CXCL8 and BD2 in keratinocytes compared with those from 
control T cells (Fig. 5 B). In contrast, both supernatants from 
HIES and control T cells almost equally well stimulated fi-
broblasts to produce CXCL8 and BD2. The combination of 
anti–IL-17A and –IL-22 efficiently inhibited the CXCL8/
BD2-inducing activity of control T cells’ supernatants in ke-
ratinocytes  but  showed  no  significant  inhibition  in  the 
CXCL8/BD2 production from fibroblasts that were stimu-
lated with the supernatants from either control or HIES   
T cells (Fig. 5 B). These results strongly suggested that Th17 
cytokines but not the Th17 cytokines (Fig. 4 D and Fig. S7). 
Conversely, in keratinocytes incubated with the Th17 cyto-
kines, the expression of the receptors for the classical proin-
flammatory cytokines was up-regulated, albeit less markedly 
(unpublished data). This reciprocal up-regulation of cytokine 
receptor expression was also observed in bronchial epithelial 
cells (unpublished data). These findings could account, at least 
in part, for the synergistic effect of the Th17 and the classical 
proinflammatory cytokines on the production of antibacterial 
factors by keratinocytes and bronchial epithelial cells.
HIES T cells show poor ability of stimulating keratinocytes 
in response to staphylococcal superantigens  
and candida antigens
We next investigated the responses of HIES T cells under 
more clinically relevant conditions to obtain a better insight 
into the susceptibility to staphylococcal infections observed 
in HIES patients. When stimulated with the S. aureus–derived 
Figure 5.  HIES T cells show poor ability of stimulating keratinocytes in response to staphylococcal superantigens and candida antigens.  
(A) PBMCs from HIES patients (Pt.) and control subjects (Cont.; n = 6 each, indicated by dots) were stimulated or not () with SEB (S, 100 ng/ml) or CAA 
(C, 1/20,000 vol/vol) for 5 d, and the concentration of the indicated cytokines in their culture supernatant was determined by ELISA. (B and C) Fibroblasts 
and keratinocytes were cultured for 48 h in the absence () or presence (S) of SEB or with the supernatants of patients (Pt.) or control (Cont.) PBMCs that 
had been unstimulated () or stimulated with SEB (S) as in A, in the presence or absence of anti–IL-17A + anti–IL-22 or isotype-matched control anti-
bodies. Their culture supernatants were analyzed by ELISA for the secretion of CXCL8 and BD2 (B) and evaluated for their neutrophil chemotactic activity 
(C). The results shown are representative of two independent experiments. Error bars show mean ± SD (n = 3). **, P < 0.01.1298 SKIN/LUNG-RESTRICTED INFECTION IN STAT3 DEFICIENCY | Minegishi et al.
patients, unlike other cell types, probably do not secrete suffi-
cient amounts of neutrophil-recruiting chemokines and the 
antimicrobial peptide BDs to fend off staphylococcal infection. 
With regard to the sites of bacterial infections, it is important 
to consider the pathogen’s characteristics. The tendency of   
S. aureus to colonize the skin and upper respiratory tract may 
explain the skin/lung-restricted staphylococcal infections ob-
served in HIES patients. It is of note, however, that CGD 
patients suffer from staphylococcal infections that occur in a 
wide variety of organs, including the lung, lymph nodes, skin, 
liver, bone, gastrointestinal tract, kidney, and brain (33). The 
difference in the spectrum of affected tissues between HIES 
and CGD patients strongly suggests that the host factors, in 
addition to the pathogen’s intrinsic factors, would determine 
the preferential sites of infections. In HIES patients, unlike   
in CGD patients, the neutrophils themselves are normal in 
their number and function; however, they probably cannot   
be recruited to the skin and lung because HIES T cells cannot 
induce the skin and lung epithelial cells to produce neutrophil-
recruiting chemokines like CXCL8, even though we cannot 
formally exclude the possibility that the STAT3 mutation   
in the epithelial cells of HIES patients also contributes to   
impaired production of antistaphylococcal factors including 
CXCL8.  Mice  deficient  for  IL-17RA  or  IL-22  and  mice 
treated with an anti–IL-17A blocking antibody are susceptible 
to infections with Gram-negative bacteria, such as K. pneu-
moniae, M. pulmonis, B. fragilis, E. coli, and Citrobacter rodentium, 
which are rarely observed in HIES patients (16, 17, 20, 21, 36, 
37). The reason for this difference between human and mouse 
in bacterial susceptibility remains to be determined.
TLR-mediated signals are known to be important for im-
mune protection from staphylococcal infections. The outer 
cell wall of Staphylococcus aureus is composed of exposed pepti-
doglycan  and  lipoteichoic  acid,  which  are  recognized  by 
TLR2 (38–40). Mice deficient in TLR2 and patients deficient 
in IRAK4, a transducer of TLR signaling, show increased 
susceptibility  to  staphylococcal  infections  (41–43).  Impor-
tantly, TLR2 signaling is intact in HIES patients (44, 45). We 
demonstrated in the present study that keratinocytes indeed 
produced antibacterial factors in response to TLR2 ligands, 
but the amounts were <10% of those induced when the cells 
were stimulated with the combination of Th17 and classical 
proinflammatory cytokines. Thus, TLR2-mediated signaling 
alone appears to be insufficient for the full protection against 
staphylococcal infection of the human skin and lung.
Skin and lung epithelial cells are located, respectively, at 
the major outer and inner surface barriers of the body, and are 
constantly exposed to agents from the environment. There-
fore, these cells probably need to discriminate between 
infectious and noninfectious agents to avoid unnecessary in-
flammation. The present study demonstrated that they secrete 
antibacterial factors only when they receive stimuli from both 
classical proinflammatory cytokines delivered by innate im-
munity–type cells and Th17 cytokines delivered by T cells. 
Thus, an attractive hypothesis is that epithelial cells have been 
equipped by evolution to respond poorly to the first alert 
cytokines secreted by SEB-stimulated T cells played a critical 
role in the induction of CXCL8 and BD2 production in ke-
ratinocytes but not in fibroblasts. In accord with these results, 
supernatants of keratinocytes stimulated with HIES T cells 
showed little or no ability of neutrophil chemoattraction, 
whereas those of keratinocytes stimulated with control T cells 
and  those  of  fibroblasts  stimulated  with  either  control  or 
HIES T cells induced robust neutrophil chemotaxis (Fig. 5 C). 
These in vitro findings may account in part, if not entirely, 
for  the  skin/lung-confined  susceptibility  to  staphylococcal 
infections observed in HIES patients.
We further examined the responsiveness of HIES T cells to 
Candida albicans antigen (CAA). HIES T cells showed impaired 
cytokine production in response to CAA in the essentially same 
pattern as observed in response to SEB (Fig. 5 A). This may also 
explain in part the incidence of mucocutaneous infections with 
C. albicans that is often observed in HIES patients.
DISCUSSION
In the present study, we demonstrated that skin and lung epi-
thelial cells displayed an unusual pattern of responsiveness to 
Th17 and other proinflammatory cytokines that was distinct 
from that of the other cell types tested. This previously unrec-
ognized modes of cytokine responses could fill in the apparent 
gap between the systemic Th17 deficiency and the tissue-
dependent susceptibility to staphylococcal infections in the 
HIES patients. Both Th17 cytokines and other classical   
proinflammatory cytokines stimulate a variety of cells to pro-
duce neutrophil-recruiting chemokines and antimicrobial 
peptides, which are important for providing protection against 
bacterial infections (7). We found that skin and lung epithelial 
cells efficiently secreted antibacterial factors only when stimu-
lated with a combination of Th17 cytokines and classical pro-
inflammatory cytokines. These observations were made using 
primary cells that were grown on plastic. In contrast, fibro-
blasts, endothelial cells, and macrophages efficiently secreted 
antibacterial factors when stimulated with the classical proin-
flammatory cytokines alone. Thus, skin and lung epithelial 
cells showed a much higher dependence on Th17 cytokines, 
in synergy with the classical proinflammatory cytokines, than 
the other cell types. The classical proinflammatory cytokines 
up-regulated the expression of Th17 cytokine receptors and, 
conversely, the Th17 cytokines up-regulated the expression 
of receptors for the classical proinflammatory cytokines, albeit 
less strongly. This reciprocal up-regulation of cytokine recep-
tor expression could be one of the molecular mechanisms 
underlying the strong synergy between the Th17 and classical 
proinflammatory cytokines in skin and lung epithelial cells.
This synergistic action of the cytokines appears to account 
in part, if not entirely, for the skin- and lung-restricted staphy-
lococcal infections of HIES patients. S. aureus produces en-
terotoxins, including SEB, that function as superantigens   
to stimulate the bulk of T cells. The HIES patients’ T cells 
showed impaired production of Th17 cytokines in response to 
SEB but normal production of the classical proinflammatory 
cytokines. Therefore, the skin and lung epithelial cells of HIES JEM VOL. 206, June 8, 2009 
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amphotericin  at  37°C  in  a  5%  CO2  incubator.  Human  primary  dermal   
fibroblasts, HUVEC, HMVEC-L were obtained from Lonza. Macrophages 
were derived from adherent cells in PBMCs cultured in the presence of   
30 ng/ml GM-CSF for 7 d.
RNA isolation and real-time quantitative RT-PCR. Cells were har-
vested for total RNA isolation using the RNeasy Miniprep kit (QIAGEN), 
according to the manufacturer’s instructions. Total RNA was reverse tran-
scribed using the PrimeScript transcription kit (Takara Bio Inc.). An aliquot 
of the RT reaction was used as a template for real-time PCR in triplicate us-
ing a SYBR Green MasterMix (Takara Bio Inc.) on an Mx3005P thermo-
cycler  (Agilent  Technologies)  with  SYBR  green  I  dye  as  the  amplicon 
detector and ROX as the passive reference. The gene for HPRT was ampli-
fied as an endogenous reference. Quantification was determined using both 
a standard curve and comparative CT methods.
ELISA. Conditioned medium from cultured cells was collected after the 
cells were stimulated and stored at 80°C until use. IL-17A (eBioscience), 
IL-22 (R&D Systems), IFN-, TNF-, IL-1, CXCL8 (BD), BD2 (KOM-
ABIOTECH), and BD3 (Alpha Diagnostics) were measured in triplicate by 
ELISA according to the manufacturers’ instructions.
Bactericidal activity against S. aureus. S. aureus (strain Rosenbach 1884) 
was obtained from the National Biological Resource Center. Bactericidal 
activity was evaluated by plating serial dilutions of S. aureus mixed with the 
supernatant from keratinocytes or bronchial epithelial cells, and the CFUs 
were determined in triplicate on the next day. In some experiments, a neu-
tralizing antibody to BD3 was added to the supernatant.
Chemotaxis. Chemotaxis of neutrophils was determined in triplicate by the 
Boyden chamber technique. The migration chamber was divided into upper 
and lower compartments by a membrane with a pore size of 3 µm. The neu-
trophils were placed into the upper compartment at a concentration of 106/ml, 
and the lower compartment contained the supernatant from the kerati-
nocytes or fibroblasts grown under the conditions indicated. The chambers 
were incubated at 37° C for 1 h, and the number of neutrophils that mi-
grated to the lower chamber was counted.
Immunoblotting. Cells were lysed on ice for 30 min in lysis buffer con-
taining 1% Triton X-100, 50 mM Tris, pH 8.0, 150 mM NaCl, 2 mM 
EDTA, 2 µg/ml aprotinin, and 100 µg/ml PMSF. The cell lysates were sub-
jected to SDS-PAGE, followed by electrotransfer to PVDF membranes and 
immunoblotting with antibodies for IL-1R1, IL-1R2, and IL-1Ra (R&D 
Systems) and for tubulin (Sigma-Aldrich).
Statistical analysis. Data were compared by a two-tailed Mann-Whitney U 
test or unpaired Student’s t test. P-values < 0.05 were considered significant.
Online supplemental material. Fig. S1 shows the quantitative RT-PCR 
analysis for chemokine and BD expression in activated keratinocytes. The 
importance of IL-17A and IL-22 in stimulating keratinocytes to produce 
antistaphylococcal factors is demonstrated in Fig. S2. Fig. S3 shows the 
quantitative RT-PCR analysis for chemokine and BD expression in vari-
ous types of cells. Production of CXCL8 by keratinocytes and fibroblasts in 
response to various cytokines is displayed in Figs. S4 and S5. Fig. S6 shows 
the expression and production of antistaphylococcal factors by keratinocytes 
in response to various stimuli. Up-regulation of the Th17 cytokine receptors 
in keratinocytes in response to classical inflammatory cytokines is displayed 
in Fig. S7. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20082767/DC1.
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signal, i.e., the classical proinflammatory cytokines produced by 
innate immunity cell types, which might be evoked even by 
noninfectious agents. Infectious agents, such as S. aureus, could 
evoke the production of the second alert signal, i.e., Th17 cyto-
kines produced by T cells, in addition to the first alert signal. 
This would allow the epithelial cells to respond selectively to 
pathogens. In HIES patients, the second alert signal is not deliv-
ered because of the Th17 deficiency, which probably results in 
skin- and lung-restricted staphylococcal infections.
Accumulating evidence indicates that Th17 cells and their 
products are very important in the induction and propaga-
tion of autoimmunity (5–10). Therefore, the neutralization of 
Th17 cytokines appears to be a promising therapeutic strat-
egy for the control of inflammation in autoimmune disor-
ders. Moreover, antagonists of STAT3 are considered good 
candidates for the treatment of tumors because a variety   
of tumor cells show up-regulated STAT3 expression (46). 
However, our data indicate that such treatments would ren-
der patients susceptible to staphylococcal infection, particu-
larly of the skin and lung, as observed in HIES. Fortunately, 
our study also suggests that this undesirable side effect might 
be prevented or treated by the local application of neutro-
phil-recruiting chemokines and BDs or their derivatives.
In summary, we demonstrated in the present study that   
T cells from HIES patients, in spite of their defect in produc-
tion of Th17 cytokines, showed normal production of other   
proinflammatory cytokines including IL-1 in response to 
staphylococcal antigens, which was insufficient for triggering 
keratinocytes and bronchial epithelial cells but sufficient for 
other cell types to produce antistaphylococcal factors. This pro-
vides a possible molecular explanation for the apparent contra-
diction between the systemic Th17 deficiency and the skin- and 
lung-restricted staphylococcal infections in HIES patients.
Materials and Methods
Patients. All eight patients enrolled in this study had typical findings associ-
ated with HIES and a National Institutes of Health score >40 points (27). The 
diagnosis was confirmed by the identification of the mutations in the STAT3 
gene. The study was approved by the Tokyo Medical and Dental University 
Ethics Committee, and written informed consent was obtained from the pa-
tients. All of the patients were in a healthy state when their blood samples were 
collected. Blood samples from patients and age-matched healthy subjects were 
obtained and PBMCs were prepared by density-gradient centrifugation.
Cell culture. PBMCs were cultured in 96-well plates in RPMI medium 
1640 supplemented with 1% penicillin/streptomycin, 1% glutamine, and 
10% heat-inactivated FCS. Cultures were stimulated with a 1:100 (vol/vol) 
dilution of anti-CD3 and anti-CD28 beads (Invitrogen). For some experi-
ments, the following mAbs, cytokines, and TLR ligands were added: 20 ng/
ml IL-17A, 200 ng/ml IL-17F, and 200 ng/ml IL-22 (R&D Systems); 10 
ng/ml TNF-, 10 ng/ml IL-1, 10 ng/ml IFN- (PeproTech); neutralizing 
antibodies against IL-17, IL-22, and BD3 (R&D Systems); TLR ligands (In-
vivoGen); fixed S. aureus (EMD); SEB (Toxin Technology); and C. albicans 
skin test antigen (Torii Pharmaceutical Co., Ltd).
Culture of human keratinocytes, bronchial epithelial cells, fibro-
blasts, endothelial cells, and macrophages. Human epidermal keratino-
cytes and bronchial epithelial cells (Lonza) were propagated as adherent cells 
to plastic in RPMI 1640 medium containing bovine pituitary extract,   
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